Chlamydophila pneumoniae respiratory tract infection aggravates therapy refractory bronchitis or pneumonia in childhood

Klinische Padiatrie

Volumn 217, Issue 1, 2005, Pages 9-14

  Schmidt, Sebastian M ^a,f   Muller C E ^a   Gurtler L ^b   Bruns, R ^a   Ballke, E H ^a   Wiersbitzky, H ^c   Ehlers, M ^d   Rose, H J ^e   Wiersbitzky, S K W ^a  

^a Children's and Youth Hospital   (Germany)

^b F Loeffler Inst Med Microbiol   (Germany)

^c Centre for Radiology

^d Institute for Immunology

^e UNIVERSITY OF GREIFSWALD   (Germany)

^f Univ Klin fur Kinder Jugendmed   (Germany)

Author keywords

Bronchial Chlamydophila pneumoniae infection; Pulmonary function; Therapy refractory bronchitis or pneumonia

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM IDENTIFICATION; BRONCHITIS; BRONCHOSCOPY; BRONCHUS SECRETION; CHILD; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIAE; NONHUMAN; PNEUMONIA; POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; BRONCHITIS, CHRONIC; BRONCHOSCOPY; CHILD; CHILD, PRESCHOOL; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; LUNG VOLUME MEASUREMENTS; MALE; MICROBIAL SENSITIVITY TESTS; PNEUMONIA, BACTERIAL; PNEUMONIA, MYCOPLASMA; PNEUMONIA, PNEUMOCOCCAL; POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SUPERINFECTION;

EID: 13244273645     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-818791     Document Type: Article

References (28)

1. Blasi F, Cosentini R, Damato S et al. Chlamydia pneumoniae chronic infection increases the risk of bacterial colonization in chronic bronchitis. Am J Respir Crit Care Med 1997; 155: A592
2. Blasi F, Damato S, Cosentini R, Tarsia P, Raccanelli R, Centanni S, Allegra L. Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment. Thorax. 2002; 57: 672-676
3. Block SL, Hammerschlag MR, Hedrick J, Tyler R, Smith A, Roblin P, Gaydos C, Pham D, Quinn TC, Palmer R, McCarty J. Chlamydia pneumoniae in acute otitis media. Pediatr Infect Dis J 1997; 16: 858-862
4. Campbell LA, Melgosa MP, Hamilton DJ, Kuo CC, Grayston JT. Detection of Chlamydia pneumoniae by polymerase chain reaction. J Clin Microbiol 1992; 30: 434-439
5. Dalhoff K, Maas M. Chlamydia pneumoniae pneumonia in hospitalized patients. Chest 1996; 110: 352-356
6. DeAbate CA, Henry D, Bensch G, Jubran A, Chodosh S, Harper L, Tipping D, Talbot G-H. Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis. Chest 1998; 114: 120-130
7. Dowell SF, Peeling RW, Boman J, Carlone GM, Fields BS, Guarner J, Hammerschlag MR, Jackson LA, Kuo CC, Maass M, Messmer TO, Talkington DF, Tondella ML, Zaki SR and the C. pneumoniae Workshop participants. Standardizing Chlamydia pneumoniae assays: Recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 2001; 33: 492-503
8. Falck G, Gnarpe J, Gnarpe H. Prevalence of Chlamydia pneumoniae in healthy children and in children with respiratory tract infections. Pediatr Infect Dis J 1997; 16: 549-554
9. Gaydos CA, Roblin PM, Hammerschlag MR, Hyman CL, Eiden JJ, Schachter J, Quinn TC. Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients. J Clin Microbiol 1994; 32: 903-905
10. Gnarpe H, Gnarpe J, Lundbäck A. Evidence of 2 waves of Chlamydia pneumoniae infection in Gävle, Sweden, 1990-96. Scand J Infect Dis 1999; 31: 83-86
11. Grayston JT. Infections caused by Chlamydia pneumoniae strain TWAR. Clin Infect Dis 1992; 15: 757-763
12. Hahn DL. Chlamydia pneumoniae, asthma, and COPD: what is the evidence? Ann Allergy Asthma Immunol 1999; 83: 271-292
13. Hammerschlag MR. Chlamydia pneumoniae and the lung. Eur Respir J 2000; 16: 1001-1007
14. Hammerschlag MR, Chirgwin K, Roblin PM, Gelling M, Dumornay W, Mandel L, Smith P, Schachter J. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis 1992; 14: 178-182
15. Hyman CL, Roblin PM, Gaydos CA, Quinn TC, Schachter J, Hammerschlag MR. Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction - enzyme immunoassay and culture. Clin Infect Dis 1995; 20: 1174-1178
16. Illi S, Von Mutius E, Lau S, Bergmann R, Niggemann B, Sommerfeld C, Wahn U. Early childhood infectious diseases and the development of asthma up to school age: a birth cohort study. BMJ 2001; 322: 390-395
17. Kauppinen M, Saikku P, Kujala P, Herva E, Syrjala H. Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia. Thorax 1996; 51: 185-189
18. Miyashita N, Niki Y, Nakajima M, Fukano H, Matsushima T. Prevalence of asymptomatic infection with Chlamydia pneumoniae in subjectively healthy adults. Chest 2001; 119: 1416-1419
19. Normann E, Gnarpe J, Gnarpe H, Wettergren B. Chlamydia pneumoniae in children with acute respiratory tract infections. Acta Paediatr 1998; 87: 23-27
20. Schauer U, Rieger CHL. Behandlung von Kindern mit RSV-Infektionen: Eine retrospektive Analyse der Saison 1998/99. Klin Pädiatr 2002; 214: 37-40
21. Schmidt SM, Herrmann H, Wiersbitzky SKW. Prevalence of Chlamydia-antibodies in in-patient children with respiratory diseases. Pediatrics and Related Topics 1999; 38: 293-304
22. Schmidt SM, Müller CE, Bruns R, Wiersbitzky SKW. Bronchial Chlamydia pneumoniae infection, markers of allergie inflammation and lung-function in children. Pediatr Allergy Immunol 2001; 12: 257-265
23. Schmidt SM, Müller CE, Krechting M, Wiersbitzky H, Gürtler L, Wiersbitzky SKW. Chlamydia pneumoniae carriage and infection in hospitalized children with respiratory tract diseases. Infection 2003; 31: 410-416
24. Schmidt SM, Müller CE, Mahner B, Wiersbitzky SKW. Prevalence, rate of persistence and respiratory tract symptoms of Chlamydia pneumoniae infection in 1211 kindergarten and school age children. Pediatr Infect Dis J 2002; 21: 758-762
25. Thorn DH, Grayston JT. Infections with Chlamydia pneumoniae strain TWAR. Clin Chest Med 1991; 12: 245-256
26. Von Hertzen LC. Chlamydia pneumoniae and it's role in chronic obstructive pulmonary disease. Ann Med 1998; 30: 27-37
27. Wiersbitzky S, Ballke E-H, Fügemann S, Wascher S, Bruns R. Die diagnostische Wertigkeit der Eosinophilie in respiratorischen Sekreten bei Kindern mit chronischen nicht spezifischen Erkrankungen der Respirationsorgane (CNSRD). Z Ärztl Fortbild 1988; 82: 217-220
28. Zapletal A. Lung function in children and adolescents. Progress in Respiration Research Vol. 22, Karger, Basel 1987